TCM
CVS icon

Teza Capital Management’s CVS Health CVS Stock Holding History

Teza Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,832
Closed -$402K – 113
2025
Q2 		$402K Buy
+5,832
New +$382K 0.3% 125
2025
Q1 		– Sell
-10,704
Closed -$481K – 432
2024
Q4 		$481K Sell
10,704
-3,697
-26% -$207K 0.07% 293
2024
Q3 		$906K Buy
+14,401
New +$840K 0.1% 269
2023
Q4 		– Sell
-28,784
Closed -$2.01M – 594
2023
Q3 		$2.01M Buy
+28,784
New +$2.04M 0.33% 79
2023
Q2 		– Sell
-8,949
Closed -$665K – 602
2023
Q1 		$665K Sell
8,949
-13,743
-61% -$1.15M 0.14% 220
2022
Q4 		$2.11M Buy
22,692
+17,558
+342% +$1.69M 0.4% 57
2022
Q3 		$490K Buy
+5,134
New +$508K 0.1% 289
2022
Q2 		– Sell
-4,698
Closed -$475K – 440
2022
Q1 		$475K Sell
4,698
-4,809
-51% -$505K 0.18% 180
2021
Q4 		$981K Sell
9,507
-8,680
-48% -$802K 0.26% 116
2021
Q3 		$1.54M Buy
+18,187
New +$1.52M 0.74% 29
2021
Q2 		– Sell
-47,386
Closed -$3.56M – 574
2021
Q1 		$3.56M Buy
+47,386
New +$3.45M 0.71% 28
2020
Q4 		– Sell
-9,155
Closed -$535K – 305
2020
Q3 		$535K Buy
+9,155
New +$570K 0.31% 98
2020
Q1 		– Sell
-16,213
Closed -$1.2M – 212
2019
Q4 		$1.2M Buy
16,213
+12,769
+371% +$897K 0.33% 68
2019
Q3 		$217K Sell
3,444
-2,321
-40% -$138K 0.06% 437
2019
Q2 		$314K Buy
5,765
+1,430
+33% +$77K 0.18% 199
2019
Q1 		$234K Buy
+4,335
New +$268K 0.12% 245
2018
Q3 		– Sell
-29,709
Closed -$1.91M – 412
2018
Q2 		$1.91M Buy
29,709
+13,612
+85% +$897K 0.29% 108
2018
Q1 		$1M Buy
+16,097
New +$1.15M 0.24% 177
2017
Q2 		– Sell
-10,233
Closed -$803K – 104
2017
Q1 		$803K Buy
+10,233
New +$817K 0.23% 138

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Teza Capital Management's CVS Position: Q3 2025 in Review

Teza Capital Management sold out of CVS Health (CVS) in Q3 2025, closing a stake of 5,832 shares — an estimated $402K sold.

Teza Capital Management first reported a position in CVS in Q1 2017 and held it in 19 quarters. The position peaked at $3.56M in Q1 2021. 1,838 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Teza Capital Management reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
  • Teza Capital Management sold 5,832 CVS Health shares in Q3 2025, an estimated $402K.
  • Teza Capital Management first reported a position in CVS Health in Q1 2017 and held it in 19 quarters.
  • Teza Capital Management's CVS Health position peaked at $3.56M in Q1 2021.
  • 1,838 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Teza Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.